Acorah Software Products - Accounts Production 16.1.300 false true 30 April 2023 1 May 2022 false true No description of principal activity 1 May 2023 30 April 2024 30 April 2024 08971205 Dr Victor Ogala iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08971205 2023-04-30 08971205 2024-04-30 08971205 2023-05-01 2024-04-30 08971205 frs-core:CurrentFinancialInstruments 2024-04-30 08971205 frs-core:Non-currentFinancialInstruments 2024-04-30 08971205 frs-bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 08971205 frs-bus:FilletedAccounts 2023-05-01 2024-04-30 08971205 frs-bus:Micro-entities 2023-05-01 2024-04-30 08971205 frs-bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 08971205 frs-bus:Director1 2023-05-01 2024-04-30 08971205 frs-bus:Director1 2023-04-30 08971205 frs-bus:Director1 2024-04-30 08971205 2022-04-30 08971205 2023-04-30 08971205 2022-05-01 2023-04-30 08971205 frs-core:CurrentFinancialInstruments 2023-04-30 08971205 frs-core:Non-currentFinancialInstruments 2023-04-30
Registered number: 08971205
Galex Medical Ltd
Financial Statements
For The Year Ended 30 April 2024
Balance Sheet
Registered number: 08971205
2024 2023
£ £
Current assets 7,371 12,417
Creditors: Amounts Falling Due Within One Year (120 ) (120 )
NET CURRENT ASSETS 7,251 12,297
TOTAL ASSETS LESS CURRENT LIABILITIES 7,251 12,297
Creditors: Amounts Falling After More Than One Year (7,897 ) (12,157 )
NET (LIABILITIES)/ASSETS (646 ) 140
CAPITAL AND RESERVES (646 ) 140

Notes

1. General Information
Galex Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08971205 . The registered office is Wellington House 273-275 High Street, London Colney, St Albans, Hertfordshire, AL2 1HA.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 May 2023 Amounts advanced Amounts repaid Amounts written off As at 30 April 2024
£ £ £ £ £
Dr Victor Ogala 12,279 - - - -
The director has repaid the overdrawn director's loan acccount in full within 9 months of the year-end.
Page 0
Page 1
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Victor Ogala
Director
14/01/2025